182 CHAPTER 8 Table 2. Summary of feasibility outcome measures per patient. ID Number of sessions VR-therapy session duration (min.) VR-gaming duration (min.) Session efficiency (%) Satisfaction level (VAS)a Fatigue level (Borg-RPE)b Adherence (%) 1 4 25 (20-26) 19 (19-19) 77 (71-93) 90 (75-100) 13 (13-13) 75 2 3 20 (9-31) 8 (6-9)c 50 (28-71) 75 (60-90) 10.5 (10-11) 67 3 2 10 (10-10) 3 (3-3) 25 (25-25) 75 (75-75) 13 (13-13) 50 4 3 33 (32-33) 17.0 (15-19) 52 (48-57) 85 (70-100) 11 (11-11) 67 5c 3 - - - - - 0 6 3 20 (15-20) 7 (6-7)d 39 (35-43)d 80 (80-100) 11 (9-11) 100 7 3 32 (25-40) 18 (15-22) 69 (37-73) 90 (80-90) 9 (7-9) 100 8 3 19 (18-20) 11 (10-13) 59 (53-65) 62.5 (50-75) 11 (9-13) 67 9 5 20 (12-30) 10 (8-17) 64 (34-83) 80 (70-100) 7 (7-11) 60 10 7 20 (20-20) 7 (7-7) 33 (33-33) 75 (75-75) 13 (13-13) 14 All subjects 20 (9-40) 13 (3-22) 57 (25-93) 80 (50-100) 11 (7-13) 60 Data are presented as median (min.-max.). Abbreviations: ID=patient identification; VR=virtual reality; VAS=visual analogue scale; Borg-RPE=Borg Rating of Perceived Exertion scale. Notes: aRanging from 0 to 100. bRanging from 6 to 20. cPatient 5 was too tired and short of breath to participate in VR-therapy sessions. d Missing for one VR-therapy session.
RkJQdWJsaXNoZXIy MjY0ODMw